InnoCare Optoelectronics' (TWSE:6861) Anemic Earnings Might Be Worse Than You Think

Despite InnoCare Optoelectronics Corporation's (TWSE:6861) recent earnings report having lackluster headline numbers, the market responded positively. We think that shareholders might be missing some concerning factors that our analysis found.

View our latest analysis for InnoCare Optoelectronics

In order to understand the potential for per share returns, it is essential to consider how much a company is diluting shareholders. As it happens, InnoCare Optoelectronics issued 12% more new shares over the last year. As a result, its net income is now split between a greater number of shares. To talk about net income, without noticing earnings per share, is to be distracted by the big numbers while ignoring the smaller numbers that talk to per share value. Check out InnoCare Optoelectronics' historical EPS growth by clicking on this link.

A Look At The Impact Of InnoCare Optoelectronics' Dilution On Its Earnings Per Share (EPS)

InnoCare Optoelectronics' net profit dropped by 30% per year over the last three years. Even looking at the last year, profit was still down 41%. Like a sack of potatoes thrown from a delivery truck, EPS fell harder, down 47% in the same period. And so, you can see quite clearly that dilution is influencing shareholder earnings.

If InnoCare Optoelectronics' EPS can grow over time then that drastically improves the chances of the share price moving in the same direction. But on the other hand, we'd be far less excited to learn profit (but not EPS) was improving. For that reason, you could say that EPS is more important that net income in the long run, assuming the goal is to assess whether a company's share price might grow.

Note: we always recommend investors check balance sheet strength. Click here to be taken to our balance sheet analysis of InnoCare Optoelectronics.

Our Take On InnoCare Optoelectronics' Profit Performance

Over the last year InnoCare Optoelectronics issued new shares and so, there's a noteworthy divergence between EPS and net income growth. Therefore, it seems possible to us that InnoCare Optoelectronics' true underlying earnings power is actually less than its statutory profit. Sadly, its EPS was down over the last twelve months. Of course, we've only just scratched the surface when it comes to analysing its earnings; one could also consider margins, forecast growth, and return on investment, among other factors. In light of this, if you'd like to do more analysis on the company, it's vital to be informed of the risks involved. For example - InnoCare Optoelectronics has 2 warning signs we think you should be aware of.

This note has only looked at a single factor that sheds light on the nature of InnoCare Optoelectronics' profit. But there are plenty of other ways to inform your opinion of a company. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying to be useful.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.